NAD+ Longevity Complex

Dietary supplement in liquid form (sublingual drops), which NAD+ Longevity Complex combines B Vitamins and nicotinamide which contribute to normal energy metabolism, as well as supporting the NAD+ cycle and related processes along with trimethylglycine (TMG) and a specialized functional complex of active ingredients (CA1405), consisting of ALCAR, resveratrol, D-ribose and taurine. With a pleasant peach flavor and free of stimulants, caffeine and alcohol, it offers a unique premium experience of daily support.

This is an advanced formulation, designed with molecular technology (microencapsulated), which aims to provide overall support for daily energy, mental clarity and metabolic balance, through the rational enhancement of the body's normal biochemical pathways. It contributes to normal energy production, fatigue reduction and stable nervous function. At the same time, it supports mitochondrial activity and the balance of the cellular environment, while the presence of resveratrol enhances the overall approach to well-being. The result is a clean, balanced and scientifically documented support for demanding lifestyles.

Dosage:
• Daily Cellular Support Protocol: 1 ml per day. Ideal for maintaining energy and prevention.
• Advanced Longevity Protocol: 2 ml per day (taken either 2 ml together in the morning, or in divided doses of 1 ml in the morning and 1 ml at noon). Ideal for periods of intense stress, mental fatigue or for those over 40 years of age.
Note: Prefer to take it in the morning or early afternoon, as the energy boost may affect sleep if taken late at night.

Liquid form with increased bioavailability and high gastrointestinal tolerance.

Ideal for morning use in 60–90 day cycles and easy to incorporate into combination supplement regimens.

The product complies with the applicable European regulatory requirements for dietary supplements, while The scientific bibliography of the product was developed by Genomed in collaboration with the National and Kapodistrian University of Athens on behalf of Nova Zen.

EOF notification number: 46370/15-4-2026